LJ
SSY Group Limited
LJUIF · OTC
$0.40 +0.00% (+$0.00)
Market Cap $9.32B
P/E Ratio 19.81x
Div. Yield 2.69%
ROE 6.36%
Bulios Fair Price
$0.47
16.8% upside
Current Price
$0.4
Undervalued Fair Value Overvalued
According to Bulios Fair Price, LJUIF is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
6/9Valuation
58 /100
Fair P/B 1.28x
P/S 2.24x
P/E 19.81x
Growth
5 /100
Declining Book val. growth 5.51%
FCF growth 6.67%
EPS growth 25.05%
Profitability
57 /100
Moderate FCF margin 7.20%
Op. margin 9.75%
Gross margin 38.92%
Quality
23 /100
Poor Asset turnover 0.33x
ROA 3.67%
ROIC 2.91%
Debt
64 /100
Moderate Net debt/EBITDA 2.61x
Int. coverage 3.85x
Debt/Equity 0.55x
Stability
75 /100
Stable Profitable years 6
EPS volatility 35.69%
Beta 0.53x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about LJUIF
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Ji Guang Qu
Employees
5,500
Headquarters
Hong Kong
Upcoming events
26 MAR
Earnings
Upcoming earnings report